Moderna (MRNA) FY2023 results: revenue $6.8 billion, down 64.4% on the year
Moderna, Inc. (MRNA) reported revenue of $6.8 billion for fiscal 2023, the year ended 31 December 2023, down 64.4% on the year before. Net income was -$4.7 billion, and diluted earnings per share $-12.33. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2024.
Revenue
$6.8 billion
-64.4% on the year
FY2016FY2023
Operating margin
-61.9%
48.9% a year earlier
FY2016FY2023
Net income
-$4.7 billion
FY2016FY2023
Diluted EPS
-$12.33
FY2016FY2023
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Operating cash flow
-3,118
4,981
13,620
Capital expenditure
707
400
284
+76.8%
Free cash flow
-3,825
4,581
13,336
Free cash flow margin
-55.9%
23.8%
72.2%
Cash from investing
4,206
-5,176
-8,523
Cash from financing
-1,377
-3,448
-873
Depreciation and amortisation
617
348
232
+77.3%
Share-based compensation
305
226
142
+35.0%
Buybacks
1,153
3,329
857
-65.4%
Diluted shares, weighted
382m
416m
431m
-8.2%
Shares outstanding at period end
382m
385m
403m
-0.8%
Balance sheet
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Shareholders' equity
13,854
19,123
14,145
-27.6%
Debt
0.0
0.0
0.0
Operating lease liabilities
643
92.0
106
+598.9%
Finance lease liabilities
575
912
599
-37.0%
Other liabilities
3,354
5,731
9,819
-41.5%
Total liabilities and equity
18,426
25,858
24,669
-28.7%
Goodwill
52.0
0.0
n/a
Intangible assets
44.0
0.0
n/a
Investments
10,374
15,015
10,722
-30.9%
Cash and equivalents
2,907
3,205
6,848
-9.3%
Receivables
892
1,385
3,175
-35.6%
Inventory
202
949
1,441
-78.7%
Other assets
3,955
5,304
2,483
-25.4%
Total assets
18,426
25,858
24,669
-28.7%
10-K for the year ended 31 December 2023, filed 23 February 2024: the filing.